Are you Dr. Hess?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 98 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1700 Wheeling St
Bldg F
Aurora, CO 80045Phone+1 720-723-6061
Summary
- Dr. Paul Hess, MD is a cardiologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado, North Carolina, and Massachusetts. He is affiliated with Rocky Mountain Regional Veterans Affairs Medical Center, University of Colorado Hospital, and Cheyenne VA Medical Center.
Education & Training
Duke University HospitalFellowship, Clinical Cardiac Electrophysiology, 2013 - 2015- Duke University HospitalFellowship, Cardiovascular Disease, 2009 - 2013
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
Emory University School of MedicineClass of 2006
Certifications & Licensure
CO State Medical License 2015 - 2025
NC State Medical License 2009 - 2016
MA State Medical License 2008 - 2010- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 4 citationsNational Trends in Hospital Performance in Guideline-Recommended Pharmacologic Treatment for Heart Failure at Discharge.Paul L Hess, Paula Langner, Paul A Heidenreich, Utibe Essien, Chelsea Leonard
JACC. Heart Failure. 2024-06-01 - 7 citationsOpportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction.Stanley A Swat, Haolin Xu, Larry A Allen, Stephen J Greene, Adam D DeVore
JACC. Heart Failure. 2023-08-01 - 17 citationsTrends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary InterventionSteven M. Bradley, Lisa A. Kaltenbach, Katelyn Xiang, Amit P. Amin, Paul L. Hess
JACC. Cardiovascular Interventions. 2021-08-09
Press Mentions
Heart Failure Medical Therapy Score and Clinical OutcomesSeptember 25th, 2024- Starting Indicated Heart Failure Meds in-Hospital: Progress, OpportunitiesJune 22nd, 2023
- Uptake Uncertain for Potent New LDL-Lowerer InclisiranJanuary 26th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
